Insider trades
Christopher Kim, Chairman of Apimeds Pharmaceuticals US APUS, has filed 2 purchases and 0 sales on the open market. The latest trade was on 25/10/15.
Christopher Kim
Chairman and CMO
- First filing
- 25/05/20
- Trades
- 4 trades
- Buys / sales
- 2 / 0
- 12-month net buying
- No record
- Last trade
- 25/10/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
APUS | Open-market buy | 25/05/13–25/05/14 | 25/05/15 | 27,500 sh2 trades | $1.83avg. | $50,359.2 | No record |